Disclosure under SEBI Takeover Regulations

V NGS API HOLDINGS LIMIITED September 04, 2026 National Stock E><change of India Limited BSE limited Exchange Plaza, C-1, Phirorn Jeejeebhoy Towers, Block G, Band ra Kurla Complex, Dalal Street, Mumbai-400001 Sandra (E), Mumbai - 400051 Thyrocare Technologies Limited (SSE Scrip Code: 539871; NSE Symbol: THYROCARE; ISIN: INE594H01019) 037/3, TTC MIDC, Turbhe, Navi Mumbai - 400703 Sub: Disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (''Takeover Regulations") Dear Sir/Madam, We wish to inform you that Docon Technologies Private Limited ("Docon" or the "Transferor Company") a;nd API Holldings Limited ("API" or the "Transferee Company") had filed a Scheme of Amalgamation of Docon with API, along with their respective shareholders ("the Scheme"), before the Hon'ble National Company Law Tribunal, Mumbai Bench ("NCLT"}, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. We are pleased to inform you that the Hon'ble NICLT, vide its order pronounced on August 31, 2026, has sanctioned the aforesaid Scheme of Amalgamation. The Company has received the certified copy of the order of the NCLT, which has been filed with the Registrar of Companies ("RoC"} in Form No. INC-28 on September 03, 2026. Accordingly, pursuant to the Scheme, the Scheme has become effective from September 03, 2026. Upon the Scheme becoming operative on the Effective Date i.e., September 03, 2026, Docon stood amalgamated with API, and all assets, liabilities, undertakings, rights and obligations of Docon stood transferred to and vested in API in accordance with the provisions of the Scheme. Consequently, Docon's entire shareholding in the Company, comprising 8,12,00,000 equity shares, representing 51.02% of the paid-up share capital of the Company, stood transmitted and vested to API by operation of law on the Effective Date. There was no change in the aggregate shareholding of the Promoter and Promoter Group of Thyrocare pursuant to the Scheme. CIN: U601 00MH2019PLC323444 Registered office: 4th Floor, Plot No. D-37/3, TTC MIDC Industrial area, Turbhe, Navi Mumbai- 400703 Telephone Number: +91 22 68645200 Email: corporatesecretarial@apiholdings.in Website: www.apiholdings.in V NGS API HOLDINGS LIMIITED Accordingly, we hereby submit the disclosure under Regulation 10(6) of the Takeover Regulations for taking the same on record and dissemination to the pu bllic. For APt Holdings limited Drashti S. Shah Group General Counsel and Company Secretary ICSI Membership No. - ACS 22968 CIN: U601 00MH2019PLC323444 Registered office: 4th Floor, Plot No. D-37/3, TTC MIDC Industrial area, Turbhe, Navi Mumbai- 400703 Telephone Number: +91 22 68645200 Email: corporatesecretarial@apiholdings.in Website: www.apiholdings.in V NGS API HOLDINGS LIMIITED Disclosures under Regulation 10(61 -Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers} Regulations, 2011 1. Name of the Target Company (TC) Thyrocare Technologies Limited BSE Scrip Code: 539871 NSE Symbol: THYROCARE 2. Name of the acquirer(s) API Holdings Limited 3. Name of the stock BSE Limited exchange where shares of the TC National Stock Exchange of India Limited are listed 4. Details of the transaction The Hon'ble National Company Law Tribunal, Mumba.i including rationale, if any, for the Bench ("NCLT11), vide its order pronounced on August 31, transfer/acquisition of shares. 2026, ha,s sanctioned the Scheme of Amalgama,tion of Docon Technollogies Private Limited ("Docon") with API Holdings Limited ("API") ("Scheme"), under Sections 230 to [232 and other applicable provisions of the Companies Act, 2013. The Scheme has become effective from September 03, 2026. Upon the Scheme becoming operative on the Effective Date, Docon stood amalgamated with API, and all assets, liabflities, undertakings, rights and obligations of Docon stood transferred to and vested in API in accordance with the provisions of the Scheme. Consequently, Docon's entire shareholding in the Company, comprising 8,12,00,000 equity shares, representing 51.02% of the paid-up share capital of the Company, stood transmitted and vested to API bv operation of law on the Effective Date i.e. September 03, 2026. 5. Relevant regulation under Regulation 10(1)(d)(ii,i) of the Takeover Regulations. which the acquirer is exempted from making open offer. CIN: U601 00MH2019PLC323444 Registered office: 4th Floor, Plot No. D-37/3, TTC MIDC Industrial area, Turbhe, Navi Mumbai- 400703 Telephone Number: +91 22 68645200 Email: corporatesecretarial@apiholdings.in Website: www.apiholdings.in V NGS API HOLDINGS LIMIITED 6. Whether disclosure of proposed rThe proposed acquisition does not require prior disclosure acquisition was required to be under Regulation 10(5) of the Takeover Regulations, as the made under regulation 10 (5) and acquisition is pursuant to an exemption under Regulation if so, lO(l)(d)(iii) of the Takeover Regulations. - whether disclosure was made and whether it was made within the timeline specified under the regulations. - date of filing with the stock exchange. 7. Details of acquisition Disclosures required to Whether the be made under disclosures under regulation 10{5} regulation 10(5) are actually made a. Name of the transferor/ seller Not applfcable Not applicable b. Date of acquisition Not applicable Not applicable C. Number of shares/ voting Not applicable Not applicable rights in respect of the acquisitions from each person mentioned in 7(a) above d. Total shares proposed to be Not applicable Not applicable acquired/ actually acquired as a % of diluted share capital ofTC e. Price at which shares are Not applicable Not applicable proposed to be acquired/ actually acquired 8. Shareholding details Pre-Transaction Post-Transaction No. of shares held %w.r.t No. of %w.r.t total shares total share held share capital capital of of TC TC a Each Acqui rer /Transferee("') API Holdings limited Nil Nil 8,12,00,000 51.02% b Each Seller/ Transferor Doc.on Technologies Privat 8,12,00,000 51.02% Nil Nil Limited Note: • (*} Shareholding of each entity shall be shown separately and then collectively in a group. CIN: U6010 0MH2019PLC323444 Registered office: 4th Floor, Plot No. D-37/3, TTC MIDC Industrial area, Turbhe, Navi Mumbai- 400703 Telephone Number: +91 22 68645200 Email: corporatesecretarial@apiholdings.in Website: www.apiholdings.in V NGS API HOLDINGS LIMIITED • The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acqu1irer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers. Drashti S. Shah Group General Counsel and Company Secretary ICSI Membership No. - ACS 22968 Date: September 04, 2026 Place: Navi Mumbai CIN: U601 00MH2019PLC323444 Registered office: 4th Floor, Plot No. D-37/3, TTC MIDC Industrial area, Turbhe, Navi Mumbai- 400703 Telephone Number: +91 22 68645200 Email: corporatesecretarial@apiholdings.in Website: www.apiholdings.in